Drawing for PRAZITECH

USPTO serial 88061539

PRAZITECH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DONEGAN, DANIEL P
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PRAZITECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael T. Smith

Michael T. Smith BIRCH STEWART KOLASCH & BIRCH LLP8110 Gatehouse Road, Suite 100 EastFalls Church, VA 22042UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Veterinary pharmaceutical preparations and substances, namely, cestocidesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 20, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 20, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 17, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 16, 2022EX5GSOU EXTENSION 5 GRANTED—
May 12, 2022EXT5SOU EXTENSION 5 FILED—
May 12, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 13, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 11, 2022EX4GSOU EXTENSION 4 GRANTED—
Jan 11, 2022EXT4SOU EXTENSION 4 FILED—
Jan 11, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 31, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 29, 2021EX3GSOU EXTENSION 3 GRANTED—
Jul 29, 2021EXT3SOU EXTENSION 3 FILED—
Jul 29, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 10, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 8, 2021EX2GSOU EXTENSION 2 GRANTED—
Feb 8, 2021EXT2SOU EXTENSION 2 FILED—
Feb 8, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 10, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 9, 2020EX1GSOU EXTENSION 1 GRANTED—
Oct 8, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 21, 2020NREVNOTICE OF REVIVAL - E-MAILED—
Aug 20, 2020TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Aug 20, 2020PETGPETITION TO REVIVE-GRANTED—
Aug 20, 2020PROATEAS PETITION TO REVIVE RECEIVED—
Aug 11, 2020EXT1SOU EXTENSION 1 FILED—
Jul 28, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 28, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 28, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 28, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 28, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 11, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 17, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 17, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 27, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 14, 2019ALIEASSIGNED TO LIE—
Nov 11, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 22, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 9, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Nov 9, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 9, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Nov 9, 2018CNSLSUSPENSION LETTER WRITTEN—
Nov 8, 2018DOCKASSIGNED TO EXAMINER—
Aug 7, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 4, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance